MUSTANG BIO, INC. |
Market Closed -
Other stock markets
|
Pre-market 09:16:20 am | |||
| 0.2012 USD | -4.73% |
|
0.193 | -4.08% |
| May. 15 | Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 02 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
Chart calendar Mustang Bio, Inc.
72ec68d4221dc8dbba90a2a75462c23.ngaiUIcc1ku4G-G8BKYMoHCWldP_xukpHbaINgWzFDk.-nHmP-h-lH7pd5XWbZd0-Brgzb-R8oJraOTwDlzUe1LqTNUy8HPhAYF9qA~f2dfcdc372d24171af9e3db99b007507
Upcoming events on Mustang Bio, Inc.
Past events on Mustang Bio, Inc.
| 2024-05-09 | Q1 2024 Earnings Release (Projected) |
| 2024-03-12 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-18 04:30 pm | B. Riley Securities Oncology Conference |
| 2023-12-09 08:30 pm | American Society of Hematology Meeting - Abstract Number : 2102 |
| 2023-11-14 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-27 08:35 am | Cantor Global Healthcare Conference |
| 2023-09-11 03:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-31 02:00 pm | CAR TCR Summit |
| 2023-08-30 05:00 pm | CAR TCR Summit |
| 2023-08-30 12:00 pm | CAR TCR Summit - Exploring the Future of Cell Therapy Characterization |
| 2023-08-30 12:00 pm | CAR TCR Summit - Discussing Initial Considerations When Planning for IND |
| 2023-08-29 01:00 pm | CAR TCR Summit |
| 2023-08-17 03:00 pm | H.C. Wainwright Immune Cell Engager Conference - Fireside Chat |
| 2023-08-14 04:05 pm | Q2 2023 Earnings Release |
| 2023-08-08 09:00 am | BTIG Virtual Biotechnology Conference |
| 2023-07-11 11:00 am | In Vivo Engineering of Therapeutic Cells Summit |
| 2023-06-21 01:00 pm | Annual General Meeting |
| 2023-06-15 09:30 am | Malignant Lymphoma International Conference - Abstract Number: 49 |
| 2023-06-09 12:00 pm | European Hematology Association Hybrid Congress - Abstract Number: P1097 |
| 2023-05-12 04:05 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -44,6 -41,1 -8.58% | 0,00 0,00 - | -64,6 -65,8 1.89% | 0,00 0,00 - | -47,4 -53,1 10.73% | -23,7 |
|
EBIT Million USD | Released Forecast Spread | -45,9 -40,2 -14.14% | -56,8 -48,7 -16.65% | -66,7 -64,7 -3.19% | -76,2 -76,6 0.56% | -49,3 -53,3 7.64% | -23,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -46,4 -40,6 -14.2% | -60,0 -52,4 -14.6% | -66,4 -64,3 -3.23% | -77,5 -78,7 1.43% | -51,6 -55,3 6.64% | -21,8 |
|
Net income Million USD | Released Forecast Spread | -46,4 -40,6 -14.2% | -60,0 -52,4 -14.6% | -66,4 -64,3 -3.23% | -77,5 -78,7 1.43% | -51,6 -55,3 6.64% | -21,8 |
|
EPS USD | Released Forecast Spread | -19,3 -17,0 -13.49% | -17,1 -15,2 -12.59% | -11,4 -10,9 -4.11% | -11,2 -11,4 1.64% | -6,00 -6,68 10.11% | -0,65 |
| Announcement Date | 16/03/20 | 24/03/21 | 23/03/22 | 29/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -19,0 -20,5 7.33% | -17,6 | -13,4 -14,1 5.13% | -11,4 -13,2 13.84% | -8,46 -12,5 32.34% | -4,95 -6,70 26.18% | -4,70 | -6,10 | -6,30 | |||
|
EBIT Million USD | Released Forecast Spread | -19,6 -17,7 -11.04% | -18,2 -20,5 10.91% | -18,8 -20,3 7.32% | -19,4 -19,9 2.23% | -16,3 -21,3 23.38% | -13,9 -16,2 14.2% | -11,7 -9,00 -29.53% | -8,74 -11,7 25.29% | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,8 -18,8 -5.15% | -19,1 -20,8 8.27% | -19,0 -20,7 8.33% | -19,6 -20,6 4.75% | -16,7 -22,0 23.95% | -16,2 -15,0 -8.52% | -10,1 -10,5 4.21% | -8,62 -11,6 25.72% | -5,19 -6,30 17.6% | -4,20 | -5,60 | -5,80 |
|
Net income Million USD | Released Forecast Spread | -19,8 -18,8 -5.15% | -19,1 -20,8 8.27% | -19,0 -20,7 8.33% | -19,6 -20,6 4.75% | -16,7 -22,0 23.95% | -16,2 -15,0 -8.52% | -10,1 -10,5 4.21% | -8,62 -11,6 25.72% | -5,19 -6,30 17.6% | -4,20 | -5,60 | -5,80 |
|
EPS USD | Released Forecast Spread | -3,00 -2,81 -6.67% | -2,85 -3,12 8.65% | -2,70 -2,96 8.86% | -2,70 -2,89 6.49% | -2,06 -3,01 31.56% | -2,00 -1,81 -10.65% | -1,23 -1,28 3.53% | -0,71 -1,33 46.62% | -0,46 -0,22 -109.09% | -0,13 | -0,16 | -0,15 |
| Announcement Date | 12/05/22 | 11/08/22 | 14/11/22 | 29/03/23 | 12/05/23 | 14/08/23 | 14/11/23 | 11/03/24 | 15/05/24 | - | - | - |
More events
Past sector events for Mustang Bio, Inc.
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MBIO Stock
- Calendar Mustang Bio, Inc.
